Class post mate,
Many posters would take the loss and take a 180 begin completely bashing the stock and management.
I wish you all the best to in the future hope you continue to make a killing on your investments, perhaps you can come back on board here once contracts are signed....
-------------------------------------
Back to CR8:
Anyways at this stage sitting on a $30m MC, plenty of upside imo.
What are the cons??
I think simple lack of news, we were given the image of plenty of contracts and news in pipelines but as always these things take much longer than expected.
I'm not too concerned about the end result, relationship with nationwide is great its just how long will it take?
I think management simply need to get some newsflow and new paid trial clients and perhaps throw in a F100. Just some names for the market to work with. Metlife deal, Malaysian bank deal, Australian superfunds, South East Asia firms, U.S health market....
$2.5m cash.... CR isnt too much of a concern for me until end of the year, thats a while away and surely I expect more deals to have been made by then.
Hopefully today is the early start to change of sentiment
Cheers
- Forums
- ASX - By Stock
- Ann: Investor presentation - Sydney Small Cap Showcase 2017
Class post mate, Many posters would take the loss and take a 180...
Featured News
Add ODE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.877M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $33.92K | 4.512M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 9404816 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 6649605 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 9404816 | 0.007 |
8 | 8814416 | 0.006 |
6 | 3454820 | 0.005 |
14 | 12451194 | 0.004 |
9 | 16220334 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 6649605 | 7 |
0.009 | 2488073 | 9 |
0.010 | 4077906 | 9 |
0.011 | 2785657 | 7 |
0.012 | 300000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ODE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online